LDX closed off well yesterday and new trend forming.
Sam Lanyon the ED of Lumos and Doug Ward the CEO yesterday both gave separate interviews regarding the company and products etc. Indicated that they are in talks with an Australian distributor for the core products Febridx and Viradx in addition to another major player in the US. The recent study announced also indicated the Febridx product avoids the need for unnecessary chest x-rays in kids which is a by product benefit (not marketed by the company themselves). Further cost saving to patients long term.
News coming?
Day trading pre-market open April 11, page-10
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)